INOVATe 2.0 Individualised Ovarian Cancer Treatment Through Integration of Genomic Pathology into Multidisciplinary Care - Phase 2: Evaluation, Implementation and Integration into Clinical Practice

Project Member(s): Marsh, D.

Funding or Partner Organisation: Cancer Institute NSW
Cancer Institute NSW

Start year: 2020

Publications:

Pitiyarachchi, O, Lee, YC, Sim, H-W, Srirangan, S, Mapagu, C, Kirk, J, Harnett, PR, Balleine, RL, Bowtell, DDL, Samimi, G, Brand, AH, Marsh, DJ, Beale, P, Anderson, L, Bouantoun, N, Provan, P, Ramus, SJ, DeFazio, A & Friedlander, M 2023, 'Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma', Translational Oncology, vol. 31, pp. 101638-101638.
View/Download from: Publisher's site

Yee, C, Dickson, K-A, Muntasir, MN, Ma, Y & Marsh, DJ 2022, 'Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine', Frontiers in Bioengineering and Biotechnology, vol. 10.
View/Download from: Publisher's site

FOR Codes: Cancer and Related Disorders, Medical And Health Sciences, Cancer therapy (excl. chemotherapy and radiation therapy), Clinical health

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.